Nordea Investment Management
MRNA icon

Nordea Investment Management’s Moderna MRNA Stock Holding History

Nordea Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,982
Closed -$678K – 882
2025
Q1 		$678K Buy
24,982
+97
+0.4% +$3.44K ﹤0.01% 844
2024
Q4 		$1.02M Hold
24,885
– – ﹤0.01% 802
2024
Q3 		$1.68M Sell
24,885
-8,692
-26% -$798K ﹤0.01% 727
2024
Q2 		$4.05M Buy
33,577
+2,223
+7% +$281K ﹤0.01% 566
2024
Q1 		$3.37M Buy
31,354
+123
+0.4% +$12.4K ﹤0.01% 619
2023
Q4 		$3.08M Sell
31,231
-6,940
-18% -$584K ﹤0.01% 637
2023
Q3 		$3.93M Sell
38,171
-28,944
-43% -$3.23M 0.01% 554
2023
Q2 		$8.22M Sell
67,115
-18,742
-22% -$2.5M 0.01% 417
2023
Q1 		$13.1M Sell
85,857
-1,290
-1% -$213K 0.02% 340
2022
Q4 		$15.2M Sell
87,147
-144,280
-62% -$23.6M 0.02% 323
2022
Q3 		$27.7M Sell
231,427
-26,614
-10% -$4.04M 0.04% 266
2022
Q2 		$35.5M Sell
258,041
-38,920
-13% -$5.56M 0.05% 249
2022
Q1 		$52.3M Buy
296,961
+34,570
+13% +$5.82M 0.07% 238
2021
Q4 		$65.6M Buy
262,391
+243,754
+1,308% +$71.3M 0.08% 222
2021
Q3 		$7.07M Buy
18,637
+1,953
+12% +$720K 0.01% 517
2021
Q2 		$3.92M Buy
16,684
+1,113
+7% +$199K 0.01% 632
2021
Q1 		$1.97M Buy
15,571
+2,451
+19% +$355K ﹤0.01% 693
2020
Q4 		$1.37M Buy
13,120
+278
+2% +$28.1K ﹤0.01% 724
2020
Q3 		$956K Sell
12,842
-10,564
-45% -$737K ﹤0.01% 729
2020
Q2 		$1.47M Buy
+23,406
New +$1.28M ﹤0.01% 753

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nordea Investment Management's MRNA Position: Q2 2025 in Review

Nordea Investment Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 24,982 shares — an estimated $678K sold.

Nordea Investment Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $65.6M in Q4 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Nordea Investment Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Nordea Investment Management sold 24,982 Moderna shares in Q2 2025, an estimated $678K.
  • Nordea Investment Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Nordea Investment Management's Moderna position peaked at $65.6M in Q4 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Nordea Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.